JCI insider plans NYSE sale of 10,500 shares via Morgan Stanley
Rhea-AI Filing Summary
Form 144 filing: A holder filed to sell up to 10,500 shares of common stock on the NYSE through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,281,380.10. The approximate sale date is 11/06/2025.
The shares were acquired via restricted stock vesting under a registered plan: 8,015 shares on 11/14/2023 and 2,485 shares on 12/12/2023, both for services rendered. Shares outstanding were 654,385,440 at the time stated in the notice.
Positive
- None.
Negative
- None.
Insights
Routine Rule 144 notice for a planned insider sale.
This is a standard notice of intent to sell restricted/controlled securities under Rule 144. The filing lists 10,500 common shares with an aggregate market value of $1,281,380.10, to be sold on the NYSE through Morgan Stanley Smith Barney LLC.
The shares originated from restricted stock vesting under a registered plan on 11/14/2023 (8,015) and 12/12/2023 (2,485). Actual sales depend on market conditions and holder decisions. Shares outstanding were 654,385,440 per the notice.
FAQ
What does the JCI Form 144 filing disclose?
When is the JCI Rule 144 sale expected?
How were the JCI shares acquired by the seller?
Which broker is listed for the JCI Form 144 sale?
How many JCI shares were outstanding per the notice?
On which exchange are the JCI shares to be sold?